Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.96% | $1.30B | €318.58B | 30.04% | 76 Outperform | |
| AstraZeneca | 1.45% | $963.85M | £214.25B | 31.94% | 76 Outperform | |
| Roche Holding AG | 1.42% | $943.88M | CHF252.45B | 36.57% | 73 Outperform | |
| Nestlé SA | 1.33% | $881.75M | CHF204.13B | 16.22% | 71 Outperform | |
| SAP SE | 1.28% | $848.54M | €239.26B | -9.26% | 66 Neutral | |
| Novartis AG | 1.25% | $830.10M | CHF195.80B | 9.82% | 80 Outperform | |
| HSBC Holdings | 1.24% | $820.69M | £178.86B | 43.76% | 79 Outperform | |
| Shell (UK) | 1.11% | $736.22M | £159.68B | 6.99% | 77 Outperform | |
| Siemens | 1.00% | $663.49M | €171.64B | 23.75% | 74 Outperform | |
| Toyota Motor | 0.97% | $641.54M | ¥40.36T | 16.23% | 81 Outperform |